Having thumbed our nose at the world, the US is now massively expanding its biodefense program, mostly in secretive facilities.”
According to Boyle, President Bush “sabotaged the Verification Protocol for the BWC” as it was on the verge of conclusion and success.
He said the U.S. “fully intended to get back into the research, development and testing of illegal and criminal offensive biowarfare programs.”
Boyle is the author of "Biowarfare and Terrorism," Clarity Press. And Elisa Harris, former arms control official under President Clinton, told The New York Times in 2003 "It (the administration's actions) will raise concerns in other capitals in part because the United States has fought tooth and nail to prevent the international community from strengthening the germ treaty."
Among pharmaceutical houses not in compliance with NIH disclosure requirements are:
Abbott Laboratories of Abbott Park and Worchester
Agencourt Bioscience Corp.
Antibody Science, Inc.
BASF Plant Science
Bristol-Myers Squibb and its Pharmaceutical Research Institute of Connecticut
Chiron; Discovery Genomics Inc.
DuPont Central Research and Development
Genzyme Corp. of Cambridge and Framingham, Mass.
Introgen Therapeutics; L2 Diagnostics LLC
Merck & Co. Inc., West Point
Merck & Co., Inc. and its Rahway, N.J., research site
Meridian Bioscience Inc.
Mystic, Conn., research; New Link Genetics; NovaFlora, Inc.
OSI Pharmaceuticals; Pfizer Inc.
Pfizer Pharmaceuticals of St. Louis
Schering-Plough Research Institute
Serono Research Institution
Third Wave Technologies
Federal entities involved include:
The Center for Disease Control.
The Walter Reed Army Medical Center
VA hospitals in Stratton, Va.
The Jerry Pettis Memorial hospital
The VA Pittsburgh Healthcare System.
The Idaho National Laboratory
Lawrence Livermore National Laboratory
The Oak Ridge National Laboratory
Plum Island Animal Disease Center of the U.S. Department of Homeland Security
The U.S. Department of Agriculture
Walter Reed Army Institute of Research
Navy Medical Research Center.